Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Patients
  • Contact Us

> Investor Relations

  • Home
  • About Us
    • Purpose
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • DARPin Science
    • Our DARPin Therapeutics
    • Radio-DARPins
    • Switch-DARPins
    • Scientific Publications & Presentations
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
      • General Meeting
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • IR Resources
      • Email Alerts
      • Contact IR
  • Partnering
  • Careers
  • Contact Us

> Top Menu

  • Partnering
  • Careers
  • Patients
  • Contact Us

> Investor Relations

  • Home
  • About Us
    • « Back
    • Purpose
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • DARPin Science
    • « Back
    • Our DARPin Therapeutics
    • Radio-DARPins
    • Switch-DARPins
    • Scientific Publications & Presentations
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
      • General Meeting
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR
  • Partnering
  • Careers
  • Contact Us

Investors

Investors

SHARE PRICE

> View All Stock

  • Detailed Share Information
Latest News
Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
Molecular Partners to Hold Three Poster Presentations at AACR 2026
Molecular Partners Reports Highlights and Financial Results for Full Year 2025

> View All News

  • All News
Upcoming Events
April 14, 2026
Annual General Meeting
May 12, 2026
Interim Management Statement Q1 2026
August 25, 2026
Half Year Results 2026 (unaudited)

> View All Events

  • All Events
Latest Presentation
March 12, 2026
Corporate Presentation – Full Year 2025 Financials
February 2, 2026
MP0712: First patient imaging and dosimetry data presented at TWC 2026, Clinical Outlook
January 15, 2026
44th Annual JPMorgan Healthcare Conference Presentation

> View All Presentations

  • All Presentations
Latest Financial Documents
March 12, 2026
Annual Report FY2025
October 30, 2025
Q3 Financial Statement 2025
August 25, 2025
H1 2025 Business Update and Financial Statements

> View All Reports

  • All Annual Report
Seth Lewis

Seth Lewis,
SVP Investor Relations and Strategy

Contact Seth

STAY INFORMED

Subscribe to email alerts of your choosing

SUBSCRIBE

Institutional investors:

  REQUEST 1-1 / CALL

powered by schedulR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2026 Molecular Partners.